Iradimed Stock Forecast - Market Facilitation Index
| IRMD Stock | USD 52.63 1.80 3.31% |
Iradimed Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Iradimed stock prices and determine the direction of Iradimed Co's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Iradimed's historical fundamentals, such as revenue growth or operating cash flow patterns.
Iradimed |
| Check Iradimed Volatility | Backtest Iradimed | Information Ratio |
Iradimed Trading Date Momentum
| On December 15 2024 Iradimed Co was traded for 52.63 at the closing time. The top price for the day was 54.22 and the lowest listed price was 52.29 . There was no trading activity during the period 0.0. Lack of trading volume on December 15, 2024 did not cause price change. The trading delta at closing time against the current closing price is 2.81% . |
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
| Compare Iradimed to competition |
Other Forecasting Options for Iradimed
For every potential investor in Iradimed, whether a beginner or expert, Iradimed's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Iradimed Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Iradimed. Basic forecasting techniques help filter out the noise by identifying Iradimed's price trends.Iradimed Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Iradimed stock to make a market-neutral strategy. Peer analysis of Iradimed could also be used in its relative valuation, which is a method of valuing Iradimed by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Iradimed Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Iradimed's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Iradimed's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Iradimed Market Strength Events
Market strength indicators help investors to evaluate how Iradimed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Iradimed shares will generate the highest return on investment. By undertsting and applying Iradimed stock market strength indicators, traders can identify Iradimed Co entry and exit signals to maximize returns.
Iradimed Risk Indicators
The analysis of Iradimed's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Iradimed's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting iradimed stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.44 | |||
| Semi Deviation | 1.77 | |||
| Standard Deviation | 2.06 | |||
| Variance | 4.23 | |||
| Downside Variance | 3.71 | |||
| Semi Variance | 3.12 | |||
| Expected Short fall | (1.64) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Iradimed is a strong investment it is important to analyze Iradimed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Iradimed's future performance. For an informed investment choice regarding Iradimed Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Iradimed to cross-verify your projections. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iradimed. If investors know Iradimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iradimed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0) | Dividend Share 0.45 | Earnings Share 1.46 | Revenue Per Share 5.635 | Quarterly Revenue Growth 0.11 |
The market value of Iradimed is measured differently than its book value, which is the value of Iradimed that is recorded on the company's balance sheet. Investors also form their own opinion of Iradimed's value that differs from its market value or its book value, called intrinsic value, which is Iradimed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iradimed's market value can be influenced by many factors that don't directly affect Iradimed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iradimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Iradimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iradimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.